Embed Prescription Services Into Any App – No Infrastructure Needed

01 /The Concept

Evaro gives online businesses a way to offer their customers prescription medication services – without needing to build the infrastructure themselves.

The service bundle includes:

- Two-minute online consultations delivered as short self-guided quiz sequences. - Prescription issuance handled by Evaro specialists. - Medication delivery within 24 hours of ordering. - Ongoing medical support for customers, including follow-up questions and repeat orders.

Any company can embed this into its website or app. In the simplest case, a single line of code opens a portal with the relevant services. For a deeper, more seamless integration, developers can wire Evaro's API calls throughout their own interface and wrap the output in their own UI.

Evaro holds all the required licenses and certifications, which means partner companies don't need to obtain any themselves.

Two types of businesses are natural fits. First, developers of health-adjacent apps or sellers of consumer wellness products – mental health, sexual wellness, weight management. Their users can now access the prescription services that complement whatever the core product already does. Second, companies already in healthcare that want to complete the service loop: not just consultations, but the ability to actually fulfill the prescriptions they issue.

Both types earn commission revenue on medications sold through their platform.

Evaro is based in the UK and already works with several well-known brands there – a sexual wellness retailer, a menstrual cycle tracking app, and an online pharmacy whose entire operation runs on top of Evaro's infrastructure.

The startup has been operating for some time but had raised only around $1.5 million in total. That changed when Evaro decided to scale: it quickly secured $25 million in new funding.

02 /Why It Matters

Evaro belongs to the fast-growing category of "embedded" services – where a platform's capabilities are distributed through third-party products rather than sold directly to end users.

The pattern is showing up everywhere, and for good reason. Building distribution is hard. Building the product is hard. The embedded model splits this cleanly: one party builds the infrastructure, another party owns the audience. Neither has to do both.

The category spans virtually every vertical. In commerce: Channel3 ([covered here](/review/ljudi-skoro-perestanut-pokupat-v-internete)) raised $6 million for a "product API" that lets developers embed shopping from a catalog of 50 million products. MealMe ([covered here](/review/proshhe-kormitsja-na-chuzhoj-klientskoj-baze)) raised $20.6 million for embeddable food and grocery delivery. Dealt ([covered here](/review/deshevle-budet-prisoseditsja)) raised €7 million for a marketplace of technicians – repair, installation, plumbing – embedded directly into the e-commerce stores that sell those products.

In financial services: Uprise ([covered here](/review/vygodnee-ne-iskat-klientov-samomu)) raised $4.7 million for embedded tax and financial advisory. Layer ([covered here](/review/kak-bystro-poluchit-100-tysjach-tjoplyh-klientov)) raised $9.3 million for embeddable accounting. Upvest ([covered here](/review/broker-vnutri)) has raised $199.2 million total to let any developer add stock trading and investment services.

In insurance: Qover ([covered here](/review/vstraivaemoe-strahovanie)) raised $71.7 million for general embedded insurance. Grace ([covered here](/review/im-ne-hvataet-tolko-tebja-chtoby-dogovoritsja)) raised €5.9 million specifically for embedded jewelry insurance targeting luxury retailers.

The funding momentum across this category is not a coincidence. Distribution through partners is often faster and cheaper than building a direct sales channel. Evaro's $25M raise suggests investors believe prescription healthcare is the next category to follow the same playbook.

03 /Opportunities

There's an old observation that most people fall into one of two categories: those who can build things but can't sell them, and those who can sell things but can't build them. The rare combination of both is genuinely uncommon.

Embedded platforms are, in a sense, a structural solution to this division of labor.

- The platform builders are people who can create the product and infrastructure. - The companies that embed them are people who know how to attract users and convert them.

This isn't just a clever framing – it has real business logic behind it. The more embedded platforms that exist, the more distribution opportunities open up for people who understand an audience but don't want to build everything from scratch.

The natural direction: identify which categories of services are candidates for embedding, and build the infrastructure that makes them distributable. Useful questions: what would existing developers or sellers actually want to add to their products? What could someone with real distribution – an audience that already trusts them – offer to their users if handed the right tool?

The prescription medicine category Evaro operates in is particularly interesting because it comes with high switching costs and repeat purchase behavior – exactly the kind of economics embedded platform providers want.